M

    Mural Oncology plc (MURA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.04
    +0.00 (+0.00%)

    Market Cap: $35.38M

    Last updated: Aug 31, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    78%(7/9)
    Avg Surprise
    +2.15%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Mar 31, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $0
    Range$0 - $0
    0 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 26EST
    		-N/A---
    Dec 25
    Reported Mar 31
    		$0.00N/A+100.00%Beat+100.0%
    Sep 25
    Reported Nov 6
    		$-0.21$-0.30+30.00%Beat+88.8%
    Jun 25
    Reported Aug 4
    		$-2.78$-1.10-152.73%Miss-49.5%
    Mar 25
    Reported May 14
    		$-1.93$-1.98+2.53%Beat-4.9%
    Dec 24
    Reported Mar 11
    		$-2.01$-1.99-1.00%Miss+43.7%
    Sep 24
    Reported Nov 13
    		$-1.87$-1.97+5.08%Beat-
    Jun 24
    Reported Aug 13
    		$-1.86$-1.95+4.62%Beat-
    Mar 24
    Reported May 14
    		$-1.84$-2.66+30.83%Beat-
    Dec 23
    Reported Mar 26
    		$-3.57$-3.57+0.08%Beat-

    Key Metrics

    Valuation
    P/E Ratio-0.29EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-103.90%ROIC-173.60%
    Financial Health
    Debt/Equity0.06xInterest CoverageN/A
    Current Ratio5.90xQuick Ratio5.90x
    Trading Statistics
    Beta2.96Avg VolumeN/A
    52-Week High$2.1252-Week Low$2.02

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.04
    SMA 20$2.04
    SMA 50$2.04
    SMA 200$2.05
    EMA 10$2.04
    EMA 20$2.04
    EMA 50$2.04
    EMA 200$2.13

    MACD

    Line: N/ASignal: N/AHist: N/A

    ADX

    ADX: 36.4+DI: 11.3-DI: 24.2

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down100.0
    PSAR$2.04

    Bollinger Bands

    Upper Band$2.04
    Lower Band$2.04
    %B PositionN/A
    Band Width0.50

    RSI (14-Day)

    Neutral
    40.1

    Momentum Oscillators

    Stoch %KN/A
    Stoch %DN/A
    Williams %RN/A
    ROC (10d)N/A
    MomentumN/A
    CCI (20d)N/A
    MFI (14d)N/A

    Volatility Measures

    ATR (14d)N/A
    StdDev (20d)N/A
    Hist VolN/A

    Volume Flow

    VWAP$2.04
    OBV266.9M
    AD Line-154.7M
    CMF (20d)N/A

    Volume Metrics

    Avg Vol (20d)N/A
    Vol RatioN/A
    VWMA (20d)N/A

    Pivot Points

    R3$2.04
    R2$2.04
    R1$2.04
    Pivot Point$2.04
    S1$2.04
    S2$2.04
    S3$2.04

    Advanced Oscillators

    TSI-20.64
    Ultimate OscN/A
    KSTN/A

    Financial Data

    QuarterSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total Revenue$0$0$0$3.49M$0$0$0$2.62M$0$0$0$0
    Cost of Revenue$0$0$0$1.75M$0$0$0$613,000$0$0$0$497,000
    Gross Profit$0$0$0$-868,000$0$0$0$2.00M$0$0$0$-497,000
    Operating Expenses$3.97M$48.84M$34.38M$35.85M$34.10M$34.28M$34.03M$58.51M$46.31M$47.26M$44.16M$57.59M
    R&D$-4,288,000$23.28M$27.43M$28.67M$27.59M$27.54M$26.87M$42.24M$40.35M$42.53M$40.41M$45.27M
    SG&A$8.25M$8.08M$6.96M$7.18M$6.51M$6.73M$7.17M$16.27M$5.96M$4.73M$3.75M$12.31M
    Operating Income$-3,966,000$-48,842,000$-34,384,000$-35,854,000$-34,098,000$-34,277,000$-34,033,000$-58,512,000$-46,313,000$-47,257,000$-44,156,000$-57,585,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$8.27M$0$0$0$0$0$0$0$0
    Income Before Tax$-3,706,000$-47,983,000$-33,156,000$-44,123,000$-31,759,000$-31,544,000$-30,991,000$-58,512,000$-46,313,000$-47,257,000$-44,156,000$-57,585,000
    Income Tax Expense$0$0$0$0$0$0$0$1.98M$4.97M$2.91M$2.31M$1.22M
    Net Income$-3,706,000$-47,982,000$-33,137,000$-34,274,000$-31,759,000$-31,564,000$-30,917,000$-59,537,000$-51,279,000$-50,164,000$-46,467,000$-58,805,000
    EBITDA$-2,909,000$-46,844,000$-32,401,000$-43,892,000$-31,452,000$-33,014,000$-30,145,000$-57,899,000$-45,534,000$-46,612,000$-43,626,000$-57,088,000
    EBIT$-3,706,000$-47,983,000$-33,156,000$-44,123,000$-31,759,000$-31,544,000$-30,991,000$-58,512,000$-46,313,000$-47,257,000$-44,156,000$-57,585,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MURA

    News

    No news available

    Company news will appear here when available

    Frequently Asked Questions About MURA

    Does MURA pay dividends?
    Mural Oncology plc (MURA) does not currently pay a regular dividend.
    What is MURA's market cap?
    Mural Oncology plc (MURA) has a market capitalization of $35.38M with a current stock price of $2.04.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In